Lee Juhan, Hinds Josephine T, Dai Hongying Daisy, Weinberger Andrea H
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York; Department of Epidemiology and Population Health, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York.
Department of Psychological, Health, & Learning Sciences, The University of Houston, Houston, Texas.
Am J Prev Med. 2025 Apr;68(4):717-725. doi: 10.1016/j.amepre.2024.12.014. Epub 2024 Dec 24.
Given the negative health outcomes of tobacco and cannabis co-use, understanding the co-use of tobacco and cannabis is important, particularly regarding those with higher health burdens, such as sexual minority individuals. This study examined the co-use of tobacco and cannabis by sexual identity.
The adult sample from the 2022 National Survey on Drug Use and Health was used for this study. A multinomial logistic regression was performed on past-month tobacco and cannabis use (i.e., no use of tobacco and cannabis [reference], tobacco only use, cannabis only use, tobacco and cannabis co-use) by sexual identity (i.e., heterosexual (reference), gay/lesbian, bisexual), adjusting for demographics. Data were collected in 2022, and statistical analyses were performed in 2024.
Among the overall adult sample, 15.8% (weighted) reported past-month tobacco only use, 7.4% reported past-month cannabis only use, and 8.5% reported past-month tobacco and cannabis co-use. Among female adults, tobacco and cannabis co-use was more likely to be reported by lesbian females (aRRR=3.83, 95% CI=2.51, 5.84) and bisexual females (aRRR=6.48, 95% CI=5.17, 8.11), compared with heterosexual females. Among male adults, tobacco and cannabis co-use was more likely to be reported by gay males (aRRR=1.68, 95% CI=1.05, 2.68) and bisexual males (aRRR=1.94, 95% CI=1.42, 2.66), compared with heterosexual males.
This study observed high levels of tobacco and cannabis co-use among sexual minority individuals. Future research should examine factors that influence tobacco and cannabis co-use for sexual minority individuals.
鉴于烟草和大麻共同使用对健康有负面影响,了解烟草和大麻的共同使用情况很重要,特别是对于那些健康负担较重的人群,如性少数群体。本研究按性取向调查了烟草和大麻的共同使用情况。
本研究使用了2022年全国药物使用和健康调查的成年样本。对过去一个月内按性取向(即异性恋(参照组)、男同性恋/女同性恋、双性恋)划分的烟草和大麻使用情况(即不使用烟草和大麻[参照组]、仅使用烟草、仅使用大麻、烟草和大麻共同使用)进行多项逻辑回归分析,并对人口统计学因素进行调整。数据于2022年收集,统计分析于2024年进行。
在整个成年样本中,15.8%(加权)报告过去一个月仅使用烟草,7.4%报告过去一个月仅使用大麻,8.5%报告过去一个月烟草和大麻共同使用。在成年女性中,与异性恋女性相比,女同性恋者(调整后相对风险比=3.83,95%置信区间=2.51,5.84)和双性恋女性(调整后相对风险比=6.48,95%置信区间=5.17,8.11)更有可能报告烟草和大麻共同使用。在成年男性中,与异性恋男性相比,男同性恋者(调整后相对风险比=1.68,95%置信区间=1.05,2.68)和双性恋男性(调整后相对风险比=1.94,95%置信区间=1.42,2.66)更有可能报告烟草和大麻共同使用。
本研究观察到性少数群体中烟草和大麻共同使用的比例很高。未来的研究应调查影响性少数群体烟草和大麻共同使用的因素。